1.55
-2.27(-59.42%)
Currency In USD
| Previous Close | 3.82 |
| Open | 1.79 |
| Day High | 1.8 |
| Day Low | 1.54 |
| 52-Week High | 75.6 |
| 52-Week Low | 1.54 |
| Volume | 15M |
| Average Volume | 479,350 |
| Market Cap | 1.11M |
| PE | -0.05 |
| EPS | -30.6 |
| Moving Average 50 Days | 4.85 |
| Moving Average 200 Days | 8.36 |
| Change | -2.27 |
If you invested $1000 in Oragenics, Inc. (OGEN) 10 years ago, it would be worth $1.38 as of July 02, 2025 at a share price of $1.55. Whereas If you bought $1000 worth of Oragenics, Inc. (OGEN) shares 5 years ago, it would be worth $34.44 as of July 02, 2025 at a share price of $1.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants
GlobeNewswire Inc.
Yesterday at 12:31 PM GMT
SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a plac
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
GlobeNewswire Inc.
Jun 10, 2025 12:30 PM GMT
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
GlobeNewswire Inc.
May 28, 2025 11:00 AM GMT
SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Director